IP Verse

Strawman competitive analysis

Explore patent oppositions filed by Strawman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 19, 2026

Patent Number	Title	Applicant	Opposition Date
EP4349407	5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Major Depression	GH RESEARCH IRELAND	Jan 9, 2026
EP3407884	Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression Innpm1	MEMORIAL SLOAN KETTERING CANCER CENTER	Jan 7, 2026
EP3928646	Vaporization Device Systems And Methods	JUUL LABS	Dec 23, 2025
EP4034298	Continuous, Carbohydrate To Ethylene Glycol Processes	IOWA CORN PROMOTION BOARD	Dec 18, 2025
EP3303598	Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To Leukocytes	RAMOT AT TEL AVIV UNIVERSITY	Dec 15, 2025
EP4346450	Infant Formula For Feeding Infants Receiving Infant Formula And Human Breast Milk	NUTRICIA	Nov 25, 2025
EP4005556	Pharmaceutical Composition Comprising Udenafil	COREPHARM BIO	Nov 19, 2025
EP3902585	Drug Reservoir For Separate Storage Of Substances	NOVO NORDISK	Nov 18, 2025
EP4306625	Concentrated Washing Agent Composition With Improved Properties	HENKEL	Nov 12, 2025
EP3793613	Immunoconjugates	BOLT BIOTHERAPEUTICS	Sep 30, 2025

Discover the latest PTAB cases involving Strawman, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Strawman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 19, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
STRAWMAN	349	-	-	-
AMGEN	8	138	8	11
CHUGAI SEIYAKU KABUSHIKI KAISHA	3	78	-	1
NOVARTIS	6	424	-	21